IDEAYA Biosciences

(NASDAQ) IDYA

Current Price$28.18

Market Cap$2.48B

Since IPO (2019)+152%

5 Year+45%

1 Year+63%

1 Month-12%

IDEAYA Biosciences Financials at a Glance

Market Cap

$2.48B

Revenue (TTM)

$225.27M

Net Income (TTM)

$140.06M

EPS (TTM)

$-1.60

P/E Ratio

-17.66

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$28.18

Volume

867,842.345

Open

$28.59

Price

$28.18

Volume

867,842.345

Open

$28.59

Previous Close

$28.21

Daily Range

$27.88 - $29.18

52-Week Range

$17.17 - $39.28

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$28.18

Volume

867,842.345

Open

$28.59

Previous Close

$28.21

Daily Range

$27.88 - $29.18

52-Week Range

$17.17 - $39.28

IDYA News

IDYA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About IDEAYA Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

145

CEO

Yujiro S. Hata, MBA

Website

www.ideayabio.com

Headquarters

South San Francisco, CA 94080, US

IDYA Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

-81%

Net Income Margin

-62%

Return on Equity

-14%

Return on Capital

-19%

Return on Assets

-14%

Earnings Yield

-5.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.48B

Shares Outstanding

87.86M

Volume

867.84K

Avg. Volume

1.17M

Financials (TTM)

Gross Profit

$214.12M

Operating Income

$159.31M

EBITDA

$154.72M

Operating Cash Flow

$71.10M

Capital Expenditure

$2.37M

Free Cash Flow

$73.47M

Cash & ST Invst.

$639.39M

Total Debt

$27.91M

IDEAYA Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$6.56M

N/A

Gross Profit

$5.42M

N/A

Gross Margin

82.58%

N/A

Market Cap

$2.48B

N/A

Market Cap/Employee

$18.92M

N/A

Employees

131

N/A

Net Income

$98.54M

-38.0%

EBITDA

$107.40M

-29.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$642.60M

-3.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$28.25M

+10.1%

Short Term Debt

$350.00K

+13.6%

Return on Assets

-13.59%

N/A

Return on Invested Capital

-19.00%

N/A

Free Cash Flow

$76.14M

-23.5%

Operating Cash Flow

$75.17M

-24.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZLABZai Lab Limited

ZLABZai Lab Limited$20.59+1.28%

BEAMBeam Therapeutics Inc.

BEAMBeam Therapeutics Inc.$27.93-5.42%

ADPTAdaptive Biotechnologies Corporation

ADPTAdaptive Biotechnologies Corporation$12.83-2.66%

MLYSMineralys Therapeutics, Inc.

MLYSMineralys Therapeutics, Inc.$27.38+0.40%

KNSAKiniksa Pharmaceuticals, Ltd.

KNSAKiniksa Pharmaceuticals, Ltd.$56.51-3.47%

FOLDAmicus Therapeutics, Inc.

FOLDAmicus Therapeutics, Inc.$14.49+0.00%

LEGNLegend Biotech Corporation

LEGNLegend Biotech Corporation$27.55-3.67%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About IDYA

What is the current price of IDEAYA Biosciences?

IDEAYA Biosciences is trading at $28.21 per share.

What is the 52-week range for IDEAYA Biosciences?

Over the past 52 weeks, IDEAYA Biosciences has traded between $17.17 and $39.28.

How much debt does IDEAYA Biosciences have?

As of the most recent reporting period, IDEAYA Biosciences reported total debt of $28.60M.

How much cash does IDEAYA Biosciences have on hand?

IDEAYA Biosciences reported $157.52M in cash and cash equivalents in its most recent financial results.

What is IDEAYA Biosciences’s dividend yield?

IDEAYA Biosciences does not currently have a dividend yield.

IDEAYA Biosciences

IDEAYA Biosciences Financials at a Glance

IDYA News

IDEAYA (IDYA) Q2 Net Loss Improves 27%

Why Ideaya Biosciences Stock Is Plummeting Today

3 Healthcare Stocks That Surged Last Week

IDYA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About IDEAYA Biosciences

IDYA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

IDEAYA Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IDYA

What is the current price of IDEAYA Biosciences?

What is the 52-week range for IDEAYA Biosciences?

How much debt does IDEAYA Biosciences have?

How much cash does IDEAYA Biosciences have on hand?

What is IDEAYA Biosciences’s dividend yield?

Premium Investing Services